NVDA
NVIDIA Corporation
NVDA has the edge over VSH overall, supported by stronger valuation and stronger fundamentals.
VSH
Vishay Intertechnology, Inc.
VSH's outlook is improving despite an expensive valuation.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
VSH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
VSH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over VSH in the historical PE scenario, which offers more potential upside but is not a forecast.
VSH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.5x | $5.25 | -81% |
| Fair | 13x | $7.87 | -72% |
| Forward | 15x | $27.79 | — |
| Expensive | 28x | $17.33 | -38% |
| Current | 45x | $27.79 | — |
Historical ranges are pointers, not guarantees.
VSH's PE is in its expensive range at 45x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its fair range.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
VSH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
VSH has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over VSH on earnings, with more consistent year-over-year improvement.
VSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.80 | +190% |
| Q3 2026 | $0.62 | +$1.18 |
| Q2 2026 | $0.19 | +$0.83 |
| Q1 2026 | $0.01 | +$0.49 |
| Q4 2025 | -$0.07 | +$0.16 |
| Q3 2025 | -$0.56 | -190% |
| Q2 2025 | -$0.64 | -152% |
| Q1 2025 | -$0.48 | -128% |
| Q4 2024 | -$0.23 | -110% |
VSH has returned to profit: it earned $0.62 per share over the past year, after losing money the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over VSH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over VSH on profitability, with a higher operating margin.
VSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $978.9M | +24% |
| Q2 2026 | $888.6M | +17% |
| Q1 2026 | $839.2M | +17% |
| Q4 2025 | $800.9M | +12% |
| Q3 2025 | $790.6M | +7.5% |
| Q2 2025 | $762.3M | +2.8% |
| Q1 2025 | $715.2M | -4.2% |
| Q4 2024 | $714.7M | -9% |
VSH's revenue has grown year over year for six quarters in a row: $979M last quarter, up 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.4% | +7 points |
| Q2 2026 | 6% | +3.1 points |
| Q1 2026 | 2.6% | +2.5 points |
| Q4 2025 | 1.9% | +9.8 points |
| Q3 2025 | 2.4% | +4.9 points |
| Q2 2025 | 2.9% | -2.2 points |
| Q1 2025 | 0.1% | -5.6 points |
| Q4 2024 | -7.9% | -18 points |
VSH's operating margin was 9.4% last quarter, up 7 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over VSH on cash flow, with more consistent year-over-year improvement.
VSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $98.2M | +$122.9M |
| Q2 2026 | $10.2M | +$83.5M |
| Q1 2026 | -$47M | -$1.5M |
| Q4 2025 | $54.6M | +$131.8M |
| Q3 2025 | -$24.7M | -$15.7M |
| Q2 2025 | -$73.4M | +$13.9M |
| Q1 2025 | -$45.5M | -268% |
| Q4 2024 | -$77.2M | +$61.8M |
VSH's free cash flow has turned positive after two years mostly in the red: $116M over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over VSH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
VSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +8.7% | +12.9M shares |
| 1 year | +18% | +25.1M shares |
| 3 years | +15% | +20.8M shares |
| 5 years | +11% | +15.4M shares |
| Available history | +11% | +15.7M shares |
VSH has 161M diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $10,000 |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $12.5M |
| Q4 2024 | $12.6M |
VSH has spent almost nothing on buybacks in the past year.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
VSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.0x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 2.6x | Moderate |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 1.5x | Healthy |
VSH has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
VSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.2 | Neutral |
| Stochastic | 17.5 | Oversold |
VSH's weekly RSI is 44 (neutral) and its Stochastic is 18 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over VSH on valuation relative to its sector.
VSH PE vs Technology Sector
| Metric | VSH | Sector median | Relative |
|---|---|---|---|
| PE | 45x | 28x | 61% above |
| PE % | 92 | 35 | 57 pts above |
VSH is trading at 45x earnings, a 61% premium to the Technology sector's median of 28x.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
VSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.6 | 6.2% below |
| 20 week MA | $33.4 | 17% below |
| 50 week MA | $29.9 | 7.1% below |
| 100 week MA | $22.7 | 22% above |
| 200 week MA | $22.7 | 23% above |
VSH has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
VSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.3 | $20.5 | -3.9% |
| 2021 | $20.5 | $21.2 | +3.3% |
| 2022 | $21.2 | $21.4 | +1% |
| 2023 | $21.4 | $24.0 | +12% |
| 2024 | $24.0 | $17.5 | -27% |
| 2025 | $17.5 | $15.0 | -14% |
| 2026 YTD | $15.0 | $27.8 | +85% |
VSH has the edge over NVDA on returns for 2026, with the stronger performance.